Roboearth – Lifestyle
Author:
Kyowa Kirin
FDA Approves New Dosing Option for CRYSVITA® (burosumab-twza) in Adults With XLH
May 14, 2026
CRYSVITA® Now Publicly Reimbursed for the Treatment of Adults with XLH in Four Provinces and Federal Non-Insured Health Benefits Program
May 6, 2026